Form 424B5 Spyre Therapeutics, Inc.
http://archive.fast-edgar.com/20261006/A4ZZ922COZ22K26P22TO2MZ2DPT9Z22IZY82
Filed on: October 6, 2026
Form 425 Churchill Capital Corp Filed by: Churchill Capital Corp XI
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 6, 2026
CHURCHILL CAPITAL CORP XI
(Exact name of registrant as specified in its charter)
Cayman Islands 001-43020 86-1959629 (State or other jurisdiction of incorporation) ... (continue reading...)
Form 4 IPG PHOTONICS CORP For: Oct 02 Filed by: SCHERBAKOV EUGENE A
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K ROKU, INC For: Oct 06
false000142843900014284392026-10-062026-10-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
October 6, 2026
(Date of earliest event reported)
Roku, Inc.
(Exact name of registrant as specified in its charter)
... (continue reading...)
Form 424B2 MORGAN STANLEY
Pricing Supplement No. 19,015
Registration Statement Nos. 333-293641; 333-293641-01
Dated October 2, 2026
Filed pursuant to Rule 424(b)(2)
Morgan Stanley Finance LLC
Structured Investments
Callable Contingent Income Securities due October 7, 2030
Based on the Worst Performing of the Nasdaq-100®... (continue reading...)
More SEC Filings
View Older Stories-
Form S-3/A Stablecoin Development
-
Form 8-K Federal Home Loan Bank For: Sep 30
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 8-K Churchill Capital Corp For: Oct 06
-
Form 4 EnerSys For: Oct 02 Filed by: Knausenberger Lauren
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 MORGAN STANLEY
-
Form 8-K PLAYSTUDIOS, Inc. For: Sep 30
-
Form D Newton Golf Company,
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D Seiche Fund I LP
-
Form SCHEDULE 13D DarkHorse Technologies Filed by: Block Joel M
-
Form 424B2 MORGAN STANLEY
-
Form 8-K Southland Holdings, Inc. For: Sep 30
-
Form 485BXT Franklin Templeton ETF
-
Form D/A NO-0813 Fund II, a serie
-
Form 4 Elanco Animal Health For: Oct 02 Filed by: Modi Rajeev A.
-
Form D Zero Index Fund I, L.P.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Elanco Animal Health For: Oct 02 Filed by: Simmons Jeffrey N
-
Form 4 EnerSys For: Oct 02 Filed by: Habiger David C
-
Form 4 Granite Point Mortgage For: Oct 04 Filed by: Johnson Blake
-
Form 40-APP/A Stellus Capital Investme
-
Form 424B2 UBS AG
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 Aramark For: Oct 02 Filed by: Tarangelo James J.
-
Form 4 Butterfly Network, Inc. For: Oct 02 Filed by: Carlson Megan
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 AMKOR TECHNOLOGY, INC. For: Oct 02 Filed by: ALEXANDER DOUGLAS A
-
Form 4 Elanco Animal Health For: Oct 02 Filed by: VanHimbergen Robert M
-
Form FWP DEUTSCHE BANK AKTIENGESE Filed by: DEUTSCHE BANK AKTIENGESELLSCHAFT
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 BofA Finance LLC
-
Form 4 Aramark For: Oct 02 Filed by: Bruno Marc A
-
Form 424B2 UBS AG
-
Form 4 Solid Biosciences Inc. For: Oct 02 Filed by: SMITH IAN F
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 144 LuxExperience B.V. Filed by: Kliger Michael
-
Form 4 LIGAND PHARMACEUTICALS For: Oct 02 Filed by: Reardon Andrew
-
Form 4 EnerSys For: Oct 02 Filed by: Morytko Tamara
